Cabotegravir was already approved for use in England and Wales as part of a combination treatment for people living with HIV.
Historically, RSV has been associated with infants, but they are not the only group that can be affected by serious RSV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback